Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Engelhardt

Showing results (211-220 of 255) with videos related to

Pageof 26
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 16, 2016
Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision makingEllen G Engelhardt, Arwen H Pieterse, Anja van der Hout, et al.
Acta Oncologica (Stockholm, Sweden)|August 4, 2015
Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision makingMarleen Kunneman, Ellen G Engelhardt, F L Laura Ten Hove, et al.
Mutation Research|July 7, 2000
In vitro micronucleus assay with Chinese hamster V79 cells - results of a collaborative study with in situ exposure to 26 chemical substancesW von der Hude, S Kalweit, G Engelhardt, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trialRenée S J M Schmitz, Ellen G Engelhardt, Miranda A Gerritsma, et al.
BMC Medical Informatics and Decision Making|October 4, 2017
Decision support systems for incurable non-small cell lung cancer: a systematic reviewD Révész, E G Engelhardt, J J Tamminga, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2016
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 SignalingRomany A N Johnpulle, Sophie Paczesny, Dae Kwang Jung, et al.
Breast Cancer Research and Treatment|March 9, 2023
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES studyAnnemiek K E van Hemert, Josefien P van Olmen, Liesbeth J Boersma, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2024
Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice - A mixed methods studyAnouk A Kruiswijk, Ellen G Engelhardt, Lisa A E Vlug, et al.
Vaccine|June 21, 2023
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccineAleksei Ekimov, Arun B Arunachalam, Taylor Blake, et al.
Vaccine|December 17, 2009
Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere seasonIan G Barr, John McCauley, Nancy Cox, et al.
Pageof 26

Showing results (211-220 of 255) with videos related to

Sort By:
Pageof 26
European Journal of Cancer (Oxford, England : 1990)|August 16, 2016
Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision makingEllen G Engelhardt, Arwen H Pieterse, Anja van der Hout, et al.
Acta Oncologica (Stockholm, Sweden)|August 4, 2015
Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision makingMarleen Kunneman, Ellen G Engelhardt, F L Laura Ten Hove, et al.
Mutation Research|July 7, 2000
In vitro micronucleus assay with Chinese hamster V79 cells - results of a collaborative study with in situ exposure to 26 chemical substancesW von der Hude, S Kalweit, G Engelhardt, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trialRenée S J M Schmitz, Ellen G Engelhardt, Miranda A Gerritsma, et al.
BMC Medical Informatics and Decision Making|October 4, 2017
Decision support systems for incurable non-small cell lung cancer: a systematic reviewD Révész, E G Engelhardt, J J Tamminga, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2016
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 SignalingRomany A N Johnpulle, Sophie Paczesny, Dae Kwang Jung, et al.
Breast Cancer Research and Treatment|March 9, 2023
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES studyAnnemiek K E van Hemert, Josefien P van Olmen, Liesbeth J Boersma, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2024
Understanding how a personalized risk prediction tool (VALUE-PERSARC) supports informed treatment decisions of soft-tissue sarcomas patients in daily clinical practice - A mixed methods studyAnouk A Kruiswijk, Ellen G Engelhardt, Lisa A E Vlug, et al.
Vaccine|June 21, 2023
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccineAleksei Ekimov, Arun B Arunachalam, Taylor Blake, et al.
Vaccine|December 17, 2009
Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere seasonIan G Barr, John McCauley, Nancy Cox, et al.
Pageof 26